| ASRFX | MGLIX | ASRFX / MGLIX | |
| Total Expense Ratio | 0.84 | 0.93 | 90% |
| Annual Report Gross Expense Ratio | 0.84 | 0.94 | 89% |
| Fund Existence | 14 years | 17 years | - |
| Gain YTD | 12.992 | 12.679 | 102% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 360M | 2.2B | 16% |
| Annual Yield % from dividends | 2.85 | 2.96 | 96% |
| Returns for 1 year | 16.43 | 13.61 | 121% |
| Returns for 3 years | 25.61 | 18.66 | 137% |
| Returns for 5 years | 10.10 | -5.48 | -184% |
| Returns for 10 years | 39.67 | 36.73 | 108% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RWEM | 33.26 | 0.38 | +1.16% |
| Rayliant Wilshire Nxtgen Emerging Markets Equity ETF | |||
| DDIV | 46.04 | N/A | N/A |
| First Trust Dorsey Wright Momt & Div ETF | |||
| TBXU | 31.70 | N/A | N/A |
| Direxion Daily Biotech Top 5 Bull 2X ETF | |||
| BAPR | 53.28 | -0.03 | -0.05% |
| Innovator U.S. Equity Buffer ETF™ - Apr | |||
| FBT | 245.30 | -3.18 | -1.28% |
| First Trust NYSE Arca Biotech ETF | |||